Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$23.75 - $31.69 $190,878 - $254,692
-8,037 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$19.97 - $26.94 $160,498 - $216,516
8,037 New
8,037 $209,000
Q2 2021

Aug 16, 2021

SELL
$18.01 - $28.32 $280,811 - $441,565
-15,592 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$19.76 - $29.89 $308,097 - $466,044
15,592 New
15,592 $409,000
Q3 2020

Nov 16, 2020

SELL
$13.54 - $26.41 $145,175 - $283,168
-10,722 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$7.84 - $23.29 $84,060 - $249,715
10,722 New
10,722 $250,000
Q3 2019

Nov 14, 2019

SELL
$9.17 - $12.01 $409,917 - $536,871
-44,702 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$10.88 - $17.6 $486,357 - $786,755
44,702 New
44,702 $531,000

Others Institutions Holding VIVO

About MERIDIAN BIOSCIENCE INC


  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Paloma Partners Management CO Portfolio

Follow Paloma Partners Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.